Langerhans cell histiocytosis
ICD-10 C96.5 · ICD-11 2B31.2

Treatment of Langerhans Cell Histiocytosis with Central Diabetes Insipidus and Anterior Pituitary Dysfunction

Unifocal Langerhans cell histiocytosis localised to the pituitary gland or hypothalamus can produce significant endocrine consequences in adults. When the disease results in central diabetes insipidus alongside anterior pituitary dysfunction, a specific management approach applies.

Clinical Scenario

Adult with unifocal LCH of the pituitary/hypothalamus presenting with central diabetes insipidus and anterior pituitary dysfunction — recognised endocrine sequelae of this localisation.

Treatment Approach

Management in this setting centres on hormone replacement directed at the pituitary/hypothalamic endocrinopathy. The complete structured regimen is available in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

For unifocal LCH of pituitary/hypothalamus resulting in DI and anterior pituitary dysfunction, hormone replacement should be undertaken.

DOI: 10.1182/blood.2021014343

View source ↗